|
TTF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33066907387547E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-15 |
| Normal-vs-Stage2 |
9.96980276113391E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.570000E-01 |
| Stage1-vs-Stage3 |
2.528000E-01 |
| Stage1-vs-Stage4 |
2.500300E-03 |
| Stage2-vs-Stage3 |
8.235800E-01 |
| Stage2-vs-Stage4 |
6.949800E-02 |
| Stage3-vs-Stage4 |
4.512200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
5.72049999592039E-08 |
| Normal-vs-Asian |
8.44879721739744E-14 |
| Caucasian-vs-AfricanAmerican |
2.165400E-01 |
| Caucasian-vs-Asian |
6.381900E-02 |
| AfricanAmerican-vs-Asian |
9.020200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62470037423645E-12 |
| Normal-vs-Female |
1.62481139653892E-12 |
| Male-vs-Female |
9.319200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(41-60Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.9957999999608E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.227000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.125900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.545800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.103700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.814400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.063800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.849960E-02 |
| Classical-VS-Follicular |
6.852000E-01 |
| Classical-VS-Other |
9.665400E-01 |
| Classical-VS-Normal |
1.17683640610267E-14 |
| Tall-VS-Follicular |
6.083600E-02 |
| Tall-VS-Other |
4.143800E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
8.759800E-01 |
| Follicular-VS-Normal |
1.62458935193399E-12 |
| Other-VS-Normal |
5.033400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62470037423645E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
8.564400E-02 |
|
|
